A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer
2011
Objectives: To carry out a phase II multi-center study on the efficacy and safety of triple combination therapy with paclitaxel, S-1, and cisplatin in patients with unresectable/met
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
36
References
22
Citations
NaN
KQI